[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hall, 1942 - Google Patents

Clinical experiences with the sublingual administration of alpha estradiol

Hall, 1942

Document ID
17520040636411189360
Author
Hall G
Publication year
Publication venue
The Journal of Clinical Endocrinology

External Links

Snippet

Anumber of investigators have reported that when estrogens are administered orally a considerable proportion, as much as 90 per cent, is inactivated in the liver. Thus, in order to achieve the same estrogenic effect, ten times more material must be given by mouth than is …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition

Similar Documents

Publication Publication Date Title
SPRAGUE et al. Physiological effects of cortisone and pituitary adrenocorticotropic hormone (ACTH) in man
PIAMPHONGSANT Tetracycline for the treatment of pityriasis lichenoides
SOYKA et al. Effectiveness of long-term human growth hormone therapy for short stature in children with growth hormone deficiency
Tagnon Antiestrogens in treatment of breast cancer
US3265573A (en) Benzothiadiazinesulfonamide-1, 1-dioxide composition
Faure et al. Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma
GEIST et al. Androgen therapy in gynecology
Hamblen et al. Treatment of Hypoovarianism by the Sequential and Cyclic Administration of Equine and Chorionic Gonadotropins—So-Called One-Two Cyclic Gonadotropic Therapy: Summary of Five Years’ Results
KR950703359A (en) Use of parathormone, its biologically active fragments and related peptides for the treatment of pregnancy
Freed The treatment of premenstrual distress, with special consideration of the androgens
Hall Clinical experiences with the sublingual administration of alpha estradiol
DE3836862A1 (en) Composition for the transdermal administration of steroid hormones
Helmreich et al. The adrenal cortical response to surgery II. Changes in plasma and urinary corticosteroid levels in man
Epstein Triamcinolone-procaine in the treatment of zoster and postzoster neuralgia
Saito et al. Stimulation of luteinizing hormone (LH) and follicle-stimulating hormone by [d-Leu6, Des-Gly10-NH2]-LH-releasing hormone ethylamide after subcutaneous, intravaginal, and intrarectal administration to women
Boss et al. Effects of adrenal cortical extract on renal function in hypophysectomized rats
Hancock et al. The use of oestrogen/progestogen preparations in the treatment of hirsutism in the female
SEIBEL et al. Events Surrounding the Initiation of Puberty with Long Term Subcutaneous Pulsatile Gonadotropin-Releasing Hormone in a Female Patient with Kallman'Syndrome
GB1483650A (en) Pharmaceutical preparations based on mesterolone
LLOYD et al. Testosterone Cyclopentylpropionate: a long-acting androgen
Segaloff et al. Therapy of virilizing adrenal hyperplasia with hydrocortisone acetate: successful therapy with infrequent intramuscular injections
Zondek et al. Induction of uterine bleeding in amenorrhea with a single injection of precipitates of estrone and progesterone
Czernobilsky et al. Endometrial histology and parentereal estrogen-progestogen administration
KR870010871A (en) Intraoperative Treatment of Basal Cell Carcinoma by Recombinant Human Alpha Interferon
BROWN et al. Experimental alteration of the human ovarian cycle by estrogen